Mouse study reveals beneficial bacteria play crucial role in helping insulin-producing cells multiply. Exposure to ...

NASA is tracking a bus-sized asteroid that will be zooming past the Earth today at a speed of nearly 28,028 miles per hour. The space rock, known as "2025 FO6," is estimated to be about 35 feet across ...

CRISPR technology has revolutionised genetic engineering, offering unprecedented precision in DNA editing with vast implications for medicine, agriculture and conservation. Yet, its power demands ...

As we approach the new financial year, and hopefully turn a new leaf for climate reform, financial services professionals have urged investors to take stock of how far Britain has progressed both ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

BPI Private has demonstrated strong momentum, registering a 9% increase in assets under management to €9.5 billion ($10.3 ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous ...

In today’s fast-paced world, many individuals face the challenges and inconveniences associated with bladder control issues.

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adu ...

The fitness industry has perpetuated myths about this balance for decades. “Cardio kills gains” and “lifting makes you bulky” are outdated falsehoods that have kept too many people from their ideal ...

In today’s health-conscious society, maintaining balanced blood sugar levels is crucial for overall well-being. Imbalances in ...

A risk-based framework helps organizations classify and protect sensitive data while simplifying access. Jay Mukherjee, CTO, ...